Röhlig Logistics has extended its healthcare and life science GDP WeCare programme with certification of its branches in Toronto, Sydney and Melbourne and extending its network to 13 countries.
The programme has been developed in alignment with international Good Distribution Practice (GDP) guidelines, including WHO and EU regulations. Going beyond standard GDP requirements, it enables the forwarder to proactively manage quality and compliance in an increasingly complex regulatory environment through market-specific compliance measures, enhanced training protocols, and proactive quality management.
The certification focuses on key pillars of pharmaceutical logistics compliance, including temperature-controlled transport, deviation management, supplier qualification, risk assessment, and documentation standards.
Global head of healthcare and life sciences, Juancarlos Cruz, said: “By implementing our own policy and programme, we ensure consistency across our global network while proactively managing risks and strengthening reliability for our healthcare customers.”
Röhlig plans to certify additional branches worldwide in 2026.
